Centric Health Announces Appointment of Independent Director

TORONTO, Jan. 8, 2015 /CNW/ - Centric Health Corporation ("Centric Health" or "the Company") (TSX: CHH), Canada's leading diversified healthcare company, today announced that Dr. Robert M. Hollinshead has been appointed as an independent member of the Board of Directors of the Company.  Dr. Hollinshead fills the vacancy left by Mr. Camillo (Cam) di Prata, who has decided to step down from the Board of Directors to focus on his business interests. Dr. Hollinshead will participate on selected sub-committees of the Centric Health board.

"We are honored to welcome Dr. Hollinshead to the Board of Directors," said Dr. Jack Shevel, Executive Chairman, Centric Health Corporation. "Dr. Hollinshead brings a wealth of knowledge, insight and strong physician relationships resulting from his extensive experience with the Alberta Health System in particular and Canadian healthcare in general. Moreover, his participation will be valuable as Centric Health continues to pursue its strategy with the overarching objective of providing the highest quality of care and outcomes to Canadians." 

Dr. Hollinshead has had a distinguished 30-year career in medicine as both an orthopedic surgeon and through various leadership positions.  Dr. Hollinshead currently serves as a Clinical Professor for the Department of Surgery, Faculty of Medicine and an Adjunct Clinical Professor at the Faculty of Kinesiology at the University of Calgary.  He is Past President of the Alberta Medical Association and Past President of the Canadian Orthopedic Association.  Recently, Dr. Hollinshead completed his tenure as a director on the Board of MD Financial Management Inc., a physician wealth management firm which is wholly owned by the Canadian Medical Association.

Dr. Shevel added, "On behalf of the Centric Health board, I would like to thank Mr. di Prata for his guidance and counsel during a transformation period for the Company and wish him well with his business endeavors."

About Centric Health

Centric Health's vision is to be Canada's premier healthcare company, providing innovative solutions centered on patients and healthcare professionals. As a diversified healthcare company with investments in several niche service areas, Centric Health currently has operations in medical assessments, disability and rehabilitation management, physiotherapy and surgical centres, specialty pharmacy and wellness and prevention. With knowledge and experience of healthcare delivery in international markets and extensive and trusted relationships with payers, physicians, and government agencies, Centric Health is pursuing expansion opportunities into other healthcare sectors to create value for all stakeholders with an unwavering commitment to the highest quality of care. Centric Health is listed on the TSX under the symbol CHH. For further information, please visit www.centrichealth.ca.

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable Canadian securities legislation.  These forward-looking statements include, among others, statements regarding business strategy, plans and other expectations, beliefs, goals, objectives, information and statements about possible future events. Readers are cautioned not to place undue reliance on such forward-looking statements. Forward-looking statements are based on current expectations, estimates and assumptions that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Centric Health and described in the forward-looking statements contained in this press release. No assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur or, if any of them do so, what benefits Centric Health will derive there-from.

SOURCE Centric Health Corporation

For further information: Daniel Gagnon, Chief Financial Officer, Centric Health, 416-619-9417, daniel.gagnon@centrichealth.ca; Lawrence Chamberlain, Investor Relations, TMX Equicom, 416-815-0700 ext. 257, lchamberlain@tmxequicom.com